8-K

Company

SANGAMO THERAPEUTICS, INC

Filed

July 1, 2021

Period of Report

June 28, 2021

Accession Number

0001193125-21-206346

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →